Stephane N. Bach

Krasnaya St 6
Krasnoselka, KEM 650000, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.

An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 01, 2026

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.

Journal: European journal of medicinal chemistry

Published: December 10, 2025

Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Journal: Cell death discovery

Published: September 18, 2025

Research towards selective inhibition of the CLK3 kinase.

Research towards selective inhibition of the CLK3 kinase.

Journal: Beilstein journal of organic chemistry

Published: July 03, 2025

New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 08, 2025

Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Journal: RSC medicinal chemistry

Published: March 25, 2025

Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Journal: ChemMedChem

Published: October 29, 2024

Novel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation.

Novel Thiazole-Fused [4,5-g] or [5,4-g]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 14, 2024

New Fusarochromanone Derivatives from the Marine Fungus Fusarium equiseti UBOCC-A-117302.

New Fusarochromanone Derivatives from the Marine Fungus Fusarium equiseti UBOCC-A-117302.

Journal: Marine drugs

Published: August 27, 2024

Development of a novel family of antifungal agents based on a quinone methide oxime framework.

Development of a novel family of antifungal agents based on a quinone methide oxime framework.

Journal: Scientific reports

Published: August 06, 2024

Ethaverine and Papaverine Target Cyclin-Dependent Kinase 5 and Inhibit Lung Cancer Cell Proliferation and Migration.

Ethaverine and Papaverine Target Cyclin-Dependent Kinase 5 and Inhibit Lung Cancer Cell Proliferation and Migration.

Journal: ACS pharmacology & translational science

Published: January 18, 2024

Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound.

Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound.

Journal: Bioorganic & medicinal chemistry

Published: November 09, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026